™
SUMMER/FALL 2026
IN THIS ISSUE
3
Healthful Living
™
MASH The pathway from steatosis to fibrosis to cirrhosis
is a publication of PAC Media Group, Vero Beach, Florida 32963
10 The Growing Burden of Metabolic Liver Disease Epidemiology, metabolic drivers, and implications for patient care
PRESIDENT France Tanguay Kenyon
EDITORIAL DIRECTOR Valerie Latona
CREATIVE DIRECTOR Elle Chan
LEAD MEDICAL WRITER Martica Heaner, PhD
12
COPY EDITOR Carolyn Waldron
SALES DIRECTOR Renee Tulenko
Patients at Risk: Identifying MASH Early Assessing patients who may benefit from further evaluation
OPERATIONS MANAGER Ellen Reising
MEDICAL ADVISORY BOARD
14
Fernando Bril, MD Scott Isaacs, MD, FACP, FACE Wajahat Mehal, MD, PhD, DPhil
Beyond ALT & AST Screening and risk assessment for MASLD/MASH
15
© 2026 PAC Media Group. All rights reserved. This publication is intended for healthcare professionals only. The content is provided for informational purposes and is not a substitute for professional clinical judgment. Although every effort has been made to ensure accuracy, PAC Media Group and its contributors assume no responsibility for errors, omissions, or any outcomes resulting from the use of this information. Clinicians are encouraged to consult current, authoritative resources before making medical decisions. No part of this publication may be reproduced, distributed, or used in any form without prior written permission from PAC Media Group. For inquiries, contact: operations@pacmediagroup.com
When Severity Shapes Care MASH case studies in clinical management
Made with FlippingBook flipbook maker